Germantown, MD, United States of America

Monika Simmons

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1999)
  • Germantown, MD (US) (2012 - 2020)

Company Filing History:


Years Active: 1999-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Monika Simmons: Innovator in Immunology

Introduction

Monika Simmons is a prominent inventor based in Germantown, MD (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines against the dengue virus. With a total of 5 patents to her name, her work is recognized for its potential impact on public health.

Latest Patents

One of her latest patents focuses on an immune-enhancing recombinant dengue protein. This invention relates to a method for preventing, ameliorating, or treating diseases caused by the dengue virus. The method involves administering a dengue vaccine formulation in combination with a NS3 helicase polypeptide and/or its fragments. This innovative approach aims to stimulate both humoral and cell-mediated immunity to the dengue virus in affected subjects.

Career Highlights

Throughout her career, Monika has worked with notable organizations, including the USA as represented by the Secretary of the Navy and the US Government as represented by the Secretary of the Army. Her expertise in immunology has allowed her to contribute to important research and development projects.

Collaborations

Monika has collaborated with esteemed colleagues such as Kevin R. Porter and Joseph R. Putnak. These partnerships have further enhanced her research and innovation in the field of immunology.

Conclusion

Monika Simmons stands out as a dedicated inventor whose work in immunology has the potential to make a significant difference in the fight against dengue virus. Her innovative approaches and collaborations reflect her commitment to advancing public health through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…